723304-09-4Relevant articles and documents
Boron-Templated Dimerization of Allylic Alcohols to Form Protected 1,3-Diols via Acid Catalysis
Nazari, S. Hadi,Forson, Kelton G.,Martinez, Erin E.,Hansen, Nicholas J.,Gassaway, Kyle J.,Lyons, Nathan M.,Kenney, Karissa C.,Valdivia-Berroeta, Gabriel A.,Smith, Stacey J.,Michaelis, David J.
supporting information, p. 9589 - 9593 (2019/12/02)
We report an unprecedented boron-templated dimerization of allylic alcohols that generates a 1,3-diol product with two stereogenic centers in high yield and diastereoselectivity. This acid-catalyzed reaction is achieved via in situ formation of a boronic ester intermediate that facilitates selective cyclization and formation of a cyclic boronic ester product. High yields are observed with a variety of allylic alcohols, and mechanistic studies confirm the role of boron as a template for the reaction.
New and facile approach for the synthesis of (E)-α,β-unsaturated esters and ketones
China Raju, Bhimapaka,Suman, Pathi
supporting information; experimental part, p. 11840 - 11842 (2011/01/12)
A general and practical synthesis of (E)-α,β-unsaturated esters and ketones was achieved by the reaction of carbonyl compounds with ethyl-4,4,4-trifluoroacetoacetate and trifluoro-substituted 1,3-diketones in the presence of piperidine in dichloromethane at raoom temperature (≈40°C) with excellent stereoselectivity (see scheme).
Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides
Doherty, Elizabeth M.,Fotsch, Christopher,Bo, Yunxin,Chakrabarti, Partha P.,Chen, Ning,Gavva, Narender,Han, Nianhe,Kelly, Michael G.,Kincaid, John,Klionsky, Lana,Liu, Qingyian,Ognyanov, Vassil I.,Tamir, Rami,Wang, Xianghong,Zhu, Jiawang,Norman, Mark H.,Treanor, James J. S.
, p. 71 - 90 (2007/10/03)
The vanilloid receptor-1 (TRPV1 or VR1) is a member of the transient receptor potential (TRP) family of ion channels and plays a role in regulating the function of sensory nerves. A growing body of evidence demonstrates the therapeutic potential of TRPV1 modulators, particularly in the management of pain. As a result of our screening efforts, we identified (E)-3-(4-tert- butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide (1), an antagonist that blocks the capsaicin-induced and pH-induced uptake of 45Ca2+ in TRPV1-expressing Chinese hamster ovary cells with IC50 values of 17 ± 5 and 150 ± 80 nM, respectively. In this report, we describe the synthesis and structure-activity relationship of a series of N-aryl cinnamides, the most potent of which (49a and 49b) exhibit good oral bioavailability in rats (Foral = 39% and 17%, respectively).
